Home
Ethical Decision Aid
Provides balanced analysis based on utilitarianism and deontology for moral dilemmas in business, assisting managers in making value-aligned decisions.
Prompt Content
Copy
Copy
Act as a corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company discovers that its marketed drug has severe side effects in a very small subset of individuals with specific genetic markers, but the cost of recall would bankrupt the company and disrupt treatment for thousands of ordinary patients. Evaluate the ethical weights of three options—full recall, partial warning, or status quo—by combining utilitarian calculations for the greatest good with deontological duties regarding patient safety and informed consent. Provide a comprehensive recommendation that balances business survival with moral integrity, focusing on how to establish a priority sequence of values amidst conflicting interests.
Copy
Comments (0)
0/300
Recommendation
Ethical Decision Assistant
Act as a corporate ethics consultant to analyze a conflict scenario involving data privacy and commercial interests. Apply utilitarian calculations to assess overall well-being and contrast this with deontological principles to examine the inherent righteousness of the action. Finally, output a decision plan that balances stakeholder interests, complies with laws and regulations, and reflects corporate social responsibility. Focus on explaining how to maintain business sustainability while protecting user privacy, avoiding simple binary oppositions, and providing actionable ethical guidelines.
Ethical Decision Aid
Act as a corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has minor but under-disclosed side effects with long-term use. Recalling it causes massive financial loss and affects shareholder interests, while not recalling it may harm some patients' health. Please evaluate the ethical weights of both choices by combining the impact on overall well-being from a utilitarian perspective with the responsibility for honesty and patient safety from a deontological perspective, and provide a comprehensive recommendation that balances business sustainability with moral底线, focusing on how to rebuild public trust through transparent communication.
Ethical Decision Aid
Act as a corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company discovers that its marketed drug has minor but irreversible neurological side effects with long-term use, yet discontinuing it poses higher risks with no alternative therapies. Please evaluate whether the company should proactively recall and disclose this risk, integrating the utilitarian principle of maximizing happiness with the deontological principle of respecting autonomy. In your response, avoid stacking verbs like 'analyze', 'generate', or 'explain'; instead, provide a narrative that balances shareholder interests, patient safety, and public trust, offering an action plan that aligns with legal compliance and moral responsibility, while clearly articulating the ethical reasoning behind this recommendation.
Ethical Decision Support
Act as a senior corporate ethics consultant to conduct a moral risk assessment for the specific business scenario I provide. This scenario involves a conflict between cost reduction and employee welfare guarantees. You need to combine utilitarian consequence analysis with deontological responsibility principles to evaluate the impact of different decision paths on stakeholders, and point out potential reputational risks and compliance hazards. Finally, please provide a structured ethical decision recommendation, clearly stating the recommended plan and its philosophical basis, ensuring the advice aligns with legal bottom lines while reflecting corporate social responsibility, maintaining an objective, professional tone without preaching.
Ethical Decision Aid
Please analyze the following specific ethical dilemma encountered in corporate operations: A pharmaceutical company discovers that its long-listed common drug may cause severe side effects in a very small subset of patients with specific genotypes, but the recall cost is extremely high and could lead to company bankruptcy, affecting the livelihoods of thousands of employees. Please evaluate the moral rationality of three strategies—recall, partial disclosure, or maintaining the status quo—by combining the impact on overall well-being from a utilitarian perspective with the responsibility for patient informed consent and safety from a deontological perspective, and provide a recommended solution that balances the interests of all parties and aligns with the company's long-term ethical responsibilities, ensuring the analysis is logically rigorous and avoids absolute conclusions.
Ethical Decision Aid
Act as a corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company discovers that its marketed drug has mild but predictable side effects with long-term use, yet the recall cost is extremely high and could lead to bankruptcy, resulting in the job loss of thousands of employees. Please evaluate whether the company should proactively disclose and recall the drug by combining utilitarian considerations of maximizing happiness for the greatest number with deontological principles of honesty and duty, and provide comprehensive advice balancing shareholder interests, patient safety, and social responsibility.
